Boram to register process patent for orlistat.

The Central Research Center of Boram Pharmaceutical company said that the company got approval of the process patents for the similar compounds of orlistat (the active ingredient of Roche's Xenical) and its preparation of finished drugs in Korea.

Xenical, an anti-obesity drug, was developed by Roche, a gigantic multinational drug corporation, as a lipase inhibiting agent of reducing the fat ...